IP Library Patent Application 17226377
Patent Application
App. No. 17/226,377

SANDWICHED BIODEGRADABLE MICRONEEDLE

Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US None
App. No.
17/226,377
Abstract

A microneedle device for delivering therapeutic ingredients to the dermis or epidermis. The device contains biodegradable microneedles, which extend from a backing, and are sandwiched between a cap film and a film which is coextensive with the tips of the microneedles and the spaces on the backing between the microneedles.

Claims (16)

1 - 12 . (canceled)

13 . A microneedle device, comprising:

a) a cap having an upper surface and a lower surface;

b) a backing having an upper surface and a lower surface, wherein said upper surface of said backing contacts said lower surface of said cap;

c) a plurality of microneedles projecting from said lower surface of said backing, wherein said lower surface of said backing comprises a plurality of spaces between said plurality of microneedles; and

d) a film covering said plurality of spaces and said plurality of microneedles, wherein said film does not comprise bioactive agents.

14 . The method of claim 13 , wherein said plurality of microneedles comprise an active pharmaceutical ingredient.

15 . The method of claim 13 , wherein said plurality of microneedles comprise one or more agents selected from the group consisting of whole stem cells, stem cell factors, retinoic acid, botulinum toxin, and minoxidil.

16 . The method of claim 15 , wherein at least one of said whole stem cells and said stem cell factors are preserved.

17 . The microneedle device of claim 13 , wherein said plurality of microneedles comprise a polymeric blend of one or more agents selected from the group consisting of preserved stem cells and preserved stem cell factors.

18 . The microneedle device of claim 13 , wherein said plurality of microneedles comprise at least one of hyaluronic acid and conotoxin.

19 . The microneedle device of claim 13 , wherein said plurality of microneedles are biodegradable.

20 . The microneedle device of claim 13 , wherein said film is a biocompatible material.

21 . The microneedle device of claim 13 , wherein said a plurality of microneedles are configured to be positioned in the dermis.

22 . The microneedle device of claim 13 , wherein said a plurality of microneedles are configured to be positioned in the epidermis.

23 . The microneedle device of claim 13 , wherein said plurality of spaces are planar.

Assignments (3)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 8, 2026
From: STEMEDICA CELL TECHNOLOGIES, INC.
To: DUNIYA SANOSTEM INC
Reel/Frame 075940/0647 →
NUNC PRO TUNC ASSIGNMENT Recorded May 8, 2025
From: TANKOVICH, NIKOLAI; PORTNOY, VASILIY
To: STEMCUTIS, LLC
Reel/Frame 071067/0553 →
SECURITY INTEREST Recorded Dec 15, 2022
From: STEMCUTIS, LLC
To: KINSELLA CONSULTING & INVESTMENTS, LLC
Reel/Frame 062137/0043 →